Mainz Biomed logo

Mainz Biomed

MYNZNASDAQ

Mainz Biomed is a medical - diagnostics & research company in the healthcare sector on NASDAQ, led by Guido Bächler, with a market cap of $8.8M. As of Q3 2025, 11% of shares are held by 13 institutional investors, with ARMISTICE CAPITAL, LLC as the largest holder at 8.62%.

Chief Executive OfficerGuido Bächler
Market Cap$8.8M
Medical - Diagnostics & Research
Healthcare
Employees71.0

Overview

Overview of institutional ownership in MYNZ as of Q3 2025 with a market cap of $6.8M

All Institutions

Institutions
13
Value Held
$717.9K
Shares Held
481.8K
Avg Position
$55.2K
Median Position
$1.7K

Hedge Funds

Hedge Funds
1
Value Held
$587.8K
Shares Held
394.5K
Avg Position
$587.8K
Median Position
$587.8K

Ownership Breakdown

Institutional (non-HF): 1.91%Hedge Funds: 8.62%Hedge FundsRetail & Other: 89.48%Retail & Other
Institutional (non-HF)
1.91%
$130.0K
Hedge Funds
8.62%
$587.8K
Retail & Other
89.48%
$6.1M

Based on market cap of $6.8M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in MYNZ as of Q3 2025

InstitutionPosition Value
ARMISTICE CAPITAL, LLC logo
ARMISTICE CAPITAL, LLC
Hedge FundLong/Short
$587.8K
0.02% of portfolio
$76.0K
0.20% of portfolio
$22.4K
0.00% of portfolio
$14.9K
0.00% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$10.4K
0.00% of portfolio
$3.1K
0.00% of portfolio
$1.7K
0.00% of portfolio
$745.0
0.00% of portfolio
$502.0
0.00% of portfolio
$134.0
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for MYNZ in Q3 2025

Traded
+$145.5K
Buyers
5
Sellers
4
Total Bought
+$166.3K
Total Sold
$20.7K
Avg Position
$47.9K

Biggest Buyers

InstitutionNet Bought
ARMISTICE CAPITAL, LLC logo
ARMISTICE CAPITAL, LLC
Hedge FundLong/Short
+$163.2K
+109.5K shares
+$1.5K
+1.0K shares
+$1.5K
+1.0K shares
+$127.0
+85.0 shares
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
+$3.0
+-860.0 shares

Biggest Sellers

InstitutionNet Sold
L
$16.5K
11.7K shares
UBS Group AG logo
UBS Group AG
Institution
$4.2K
2.8K shares
$4.5
3.0 shares
$1.0
1.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited MYNZ in Q3 2025

New Positions
1
New Value
$127.0
Exited Positions
2
Exited Value
$16.5K

New Positions

InstitutionPosition Value
$127.0
85.0 shares

Exited Positions

InstitutionPrevious Position
L
$16.5K
11.7K shares
$1.0
1.0 shares

Options Activity

Institutions with the largest Call and Put options positions in MYNZ as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with MYNZ as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
0.20%
$76.0K
ARMISTICE CAPITAL, LLC logo
ARMISTICE CAPITAL, LLC
Hedge FundLong/Short
0.02%
$587.8K
0.00%
$22.4K
0.00%
$1.7K
0.00%
$745.0
0.00%
$14.9K
0.00%
$502.0
0.00%
$127.0
0.00%
$3.1K
0.00%
$134.0

Hedge Fund Spotlight

Discover hedge funds investing in MYNZ

ARMISTICE CAPITAL, LLC logo
ARMISTICE CAPITAL, LLC
Hedge FundLong/Short
Portfolio ManagerSteven Joseph Boyd
Portfolio Value
$3.2B
Positions
313
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Healthcare: 60.50%HealthcareTechnology: 12.50%TechnologyConsumer Cyclical: 10.10%Consumer CyclicalConsumer Defensive: 3.60%Communication Services: 2.50%Financial Services: 0.50%Industrials: 0.30%Basic Materials: 0.30%Energy: 0.20%Real Estate: 0.10%Utilities: 0.10%
Mainz Biomed logo

Position in Mainz Biomed

Market Value
$587.8K
Shares Held
394.5K
Portfolio Weight
0.02%
Owned Since
2024-Q4
Top HoldingSectorMarket ValueWeight
Biotechnology
Healthcare
$201.1M6.38%
Biotechnology
Healthcare
$160.7M5.10%
Drug Manufacturers - Specialty & Generic
Healthcare
$135.5M4.30%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.